RAC1 and neoplasm: Significantly, through cancer cell line study and orthotopic xenograft animal model, a GTP-Rac1 inhibitor demonstrated the ability to suppress tumor growth specifically in CGN c.3560C > T mutant cancer cells, contrasting with its ineffectiveness in CGN WT cancer cells.